IRWD

IRONWOOD PHARMACEUTICALS, INC.

IRWD · CIK 1446847 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$48M
20182025
Net Income−$2M
20182025
Operating CF$127M
20182025
Free Cash Flow$127M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Cost of Revenue———$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit————————
R&D Expense$0.1B$0.1B$0.1B$0.0B$0.1B$0.1B$0.1B$0.2B
SG&A Expense$0.1B$0.1B$0.2B$0.1B$0.1B$0.1B$0.2B$0.2B
Operating Income$0.1B$0.1B$-0.9B$0.3B$0.2B$0.1B$0.1B$-0.2B
Net Income$-0.0B$0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B
EPS (Basic)$-0.01$0.01$-0.01$0.32$0.25$0.27$0.31—
EPS (Diluted)$-0.01$0.01$-0.01$0.27$0.25$0.27$0.30—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.4B$0.4B$0.5B$1.1B$1.1B$0.6B$0.4B$0.3B
Current Assets$0.3B$0.2B$0.2B$0.8B$0.7B$0.5B$0.3B$0.3B
Cash & Equivalents$0.2B$0.1B$0.1B$0.7B$0.6B$0.4B$0.2B$0.2B
Total Liabilities————————
Current Liabilities$0.2B$0.0B$0.3B$0.0B$0.2B$0.0B$0.0B$0.1B
Stockholders' Equity$-0.3B$-0.3B$-0.3B$0.7B$0.6B$0.1B$-0.1B$-0.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$0.1B$0.2B$0.3B$0.3B$0.2B$0.0B$-0.1B
Investing Cash Flow$-0.0B$-0.0B$-1.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$-0.1B$0.3B$-0.2B$-0.0B$0.0B$-0.0B$0.0B
← Companies